JP2023501949A5 - - Google Patents
Info
- Publication number
- JP2023501949A5 JP2023501949A5 JP2022525282A JP2022525282A JP2023501949A5 JP 2023501949 A5 JP2023501949 A5 JP 2023501949A5 JP 2022525282 A JP2022525282 A JP 2022525282A JP 2022525282 A JP2022525282 A JP 2022525282A JP 2023501949 A5 JP2023501949 A5 JP 2023501949A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- halo
- pharmaceutically acceptable
- haloalkyl
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962927268P | 2019-10-29 | 2019-10-29 | |
| US62/927,268 | 2019-10-29 | ||
| PCT/US2020/057740 WO2021086966A1 (en) | 2019-10-29 | 2020-10-28 | Spirocyclic o-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023501949A JP2023501949A (ja) | 2023-01-20 |
| JP2023501949A5 true JP2023501949A5 (enExample) | 2023-11-06 |
Family
ID=73554493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525282A Ceased JP2023501949A (ja) | 2019-10-29 | 2020-10-28 | スピロ環ｏ－糖タンパク質－２－アセトアミド－２－デオキシ－３－ｄ－グルコピラノシダーゼ阻害剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12565504B2 (enExample) |
| EP (1) | EP4051682A1 (enExample) |
| JP (1) | JP2023501949A (enExample) |
| CN (1) | CN114929709B (enExample) |
| AR (1) | AR120324A1 (enExample) |
| TW (1) | TW202130643A (enExample) |
| UY (1) | UY38934A (enExample) |
| WO (1) | WO2021086966A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022095971A1 (zh) * | 2020-11-06 | 2022-05-12 | 上海医药集团股份有限公司 | 一种螺杂环类化合物、其制备方法及应用 |
| WO2025247394A1 (zh) * | 2024-05-31 | 2025-12-04 | 纽欧申医药(上海)有限公司 | 含氮杂环化合物、其药物组合物及应用 |
| CN119569746B (zh) * | 2025-02-06 | 2025-05-13 | 纽欧申医药(上海)有限公司 | 含氮杂环化合物、其药物组合物及应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| US5948807A (en) * | 1997-09-03 | 1999-09-07 | Regents Of The University Of Minnesota | Spiroindanamines and Spiroindanimides |
| WO2007063385A2 (en) * | 2005-12-01 | 2007-06-07 | Pfizer Products Inc. | Spirocyclic amine histamine-3 receptor antagonists |
| EP1847542A1 (en) * | 2006-04-21 | 2007-10-24 | Laboratorios del Dr. Esteve S.A. | Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor |
| ATE486877T1 (de) | 2006-12-29 | 2010-11-15 | Hoffmann La Roche | Azaspiroderivate |
| WO2010141074A2 (en) * | 2009-06-01 | 2010-12-09 | President And Fellows Of Harvard College | O-glcnac transferase inhibitors and uses thereof |
| AU2012298949B2 (en) * | 2011-08-25 | 2016-09-22 | Merck Patent Gmbh | Pyrano [3, 2 - D] [1, 3] thiazole as glycosidase inhibitors |
| US9051269B2 (en) | 2011-11-18 | 2015-06-09 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| EP2780014A4 (en) | 2011-11-18 | 2015-07-01 | Constellation Pharmaceuticals Inc | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF |
| WO2013078320A1 (en) | 2011-11-21 | 2013-05-30 | Constellation Pharmaceuticals | Modulators of methyl modifying enzymes, compositions and uses thereof |
| JP5989805B2 (ja) | 2012-02-10 | 2016-09-07 | コンステレーション・ファーマシューティカルズ・インコーポレイテッドＣｏｎｓｔｅｌｌａｔｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | メチル基変更酵素の調節物質、組成物及びその使用 |
| MA38341B1 (fr) | 2013-02-11 | 2018-11-30 | Constellation Pharmaceuticals Inc | Modulateurs d'enzymes de modification par méthylation, compositions et utilisations associées |
| PT2970272T (pt) * | 2013-03-14 | 2019-06-05 | Merck Patent Gmbh | Inibidores de glicosidase |
| US9745305B2 (en) | 2013-03-15 | 2017-08-29 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| US9969716B2 (en) | 2013-08-15 | 2018-05-15 | Constellation Pharmaceuticals, Inc. | Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof |
| NZ727185A (en) * | 2014-06-24 | 2018-04-27 | Gilead Sciences Inc | Phosphatidylinositol 3-kinase inhibitors |
| CN107912040B (zh) * | 2014-10-10 | 2021-04-06 | 基因泰克公司 | 作为组蛋白脱甲基酶抑制剂的吡咯烷酰胺化合物 |
| SMT202100699T1 (it) * | 2016-06-16 | 2022-01-10 | Denali Therapeutics Inc | Pirimidin-2-ilammino-1h-pirazoli come inibitori di lrrk2 per l'uso nel trattamento di disturbi neurodegenerativi |
| US11186564B2 (en) * | 2016-08-04 | 2021-11-30 | Sunovion Pharmaceuticals Inc. | Dual NAV1.2/5HT2a inhibitors for treating CNS disorders |
| AU2018216040A1 (en) | 2017-02-06 | 2019-06-20 | Janssen Pharmaceutica Nv | OGA inhibitor compounds |
-
2020
- 2020-10-28 AR ARP200102980A patent/AR120324A1/es unknown
- 2020-10-28 CN CN202080091113.0A patent/CN114929709B/zh active Active
- 2020-10-28 WO PCT/US2020/057740 patent/WO2021086966A1/en not_active Ceased
- 2020-10-28 US US17/772,646 patent/US12565504B2/en active Active
- 2020-10-28 EP EP20812162.4A patent/EP4051682A1/en not_active Withdrawn
- 2020-10-28 TW TW109137522A patent/TW202130643A/zh unknown
- 2020-10-28 UY UY0001038934A patent/UY38934A/es not_active Application Discontinuation
- 2020-10-28 JP JP2022525282A patent/JP2023501949A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023501949A5 (enExample) | ||
| JP2021518340A5 (enExample) | ||
| JP4520533B2 (ja) | 縮合アミノジヒドロチアジン誘導体 | |
| EP2297120B1 (en) | Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease | |
| JP2022500472A5 (enExample) | ||
| JP2014503527A5 (enExample) | ||
| NO20045528L (no) | MHC1R-antagonister | |
| JP2020535165A5 (enExample) | ||
| JP2023512821A5 (enExample) | ||
| JP2013541596A5 (enExample) | ||
| JP2012532125A5 (enExample) | ||
| CN104411709B (zh) | 可用作阿尔茨海默病的诊断剂的咪唑并[2，1]噻唑-3-酮衍生物 | |
| JP2022519639A5 (enExample) | ||
| IL147505A (en) | Pyrolidines and neurotrophic piperidines and their use in the preparation of drugs containing them | |
| Shingade et al. | Synthesis and antimicrobial screening of 4-thiazolidinone and 2-azetidinone derivatives of piperazine | |
| JP2022510430A5 (enExample) | ||
| CA2475137A1 (fr) | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| EP1753719B1 (en) | Substituted pyrrolidine-2-ones | |
| JP2022524077A5 (enExample) | ||
| Swaleh et al. | New strategy for the synthesis of iminoglycitols from amino acids | |
| JP2020525417A5 (enExample) | ||
| US11306089B2 (en) | Gamma-carboline compounds for the detection of Tau aggregates | |
| JP2007517855A5 (enExample) | ||
| WO2024019916A2 (en) | Chromane amidine monobactam compounds for the treatment of bacterial infections | |
| HK1206343B (en) | Imidazo[2,1]thiazol-3-one derivatives useful as diagnostic agents for alzheimer's disease |